ClinicalTrials.gg
Sign In

Atherosclerosis clinical trials

The registry lists 1,517 studies for Atherosclerosis across more than 10 countries. 224 are recruiting or about to start. 706 of them are mainly about Atherosclerosis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 3 narrower conditions too, such as Peripheral Arterial Disease: 3,101 studies, 534 open.

ClinicalTrials.gov finds 3,627 studies for Atherosclerosis. How that becomes 1,517 here

This page counts the studies the registry files under Atherosclerosis, and those it files under no condition that list Atherosclerosisthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 3,627Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −1,481Filed under a narrower condition, counted on its own pagePeripheral Arterial Disease 1,264 · Chronic Limb-Threatening Ischemia 216 · Intermittent Claudication 1
  3. −293List Atherosclerosis as a condition, but the registry did not file them under itMost often written as “Coronary Atherosclerosis” (63), “Carotid Atherosclerosis” (53), and “Intracranial Atherosclerosis” (44). The registry filed 13 of them under no condition at all, and the others under other conditions only, most often Coronary Artery Disease (125) and Intracranial Arteriosclerosis (67).
  4. −336Match it another way242 name it in the title, 43 in a keyword, and 51 by a synonym or other text the search reads.
  5. 1,517The count on this page29 of them list Atherosclerosis in their own words; the registry filed them under no condition.

Get an email when these change. Save the Atherosclerosis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
895
Status unknown
215
Recruiting
161
Terminated
73
Active, not recruiting
68
Not yet recruiting
53

Phase

Phase 4
183
Phase 2
158
Phase 3
150
Phase 1
78
Early Phase 1
14

Where

United States
468
China
111
Netherlands
102
Canada
91
United Kingdom
88
Italy
81

Who runs them

National Heart, Lung, and Blood Institute (NHLBI) (91) · GlaxoSmithKline (32) · Novartis Pharmaceuticals (22) · Massachusetts General Hospital (20) · Boston Scientific Corporation (20) · AstraZeneca (17) · Korea University (15) · Organon and Co (14)

What is being tested here

Drugs under test in Atherosclerosis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Colchicine6416
Aspirin4421
Inclisiran3816
Metformin328
Ezetimibe2622
Evolocumab208
Atorvastatin1624
Clopidogrel1310
Bempedoic acid167
Alirocumab115

Drug classes tested here Antimitotic agents 6 open · Statins 5 open · NSAIDs 4 open · PCSK9 inhibitors 3 open · P2Y12 inhibitors 2 open

Coming up

24phase 3 studies under way
75studies finish main data collection within a year6 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 161 Atherosclerosis studies recruiting now, 84 (52%) set no upper age limit and 33 (20%) stop at 75 or younger. 16 (10%) take children under 18. 2 (1%) are for women only and 3 (2%) for men only; 33 (20%) take healthy volunteers.

Recruiting studies that take each age, of 161
AgeWomenMen
1014 (9%)13 (8%)
1899 (61%)100 (62%)
30121 (75%)121 (75%)
40138 (86%)139 (86%)
50151 (94%)153 (95%)
65150 (93%)152 (94%)
75139 (86%)140 (87%)
85106 (66%)106 (66%)

Across all 1,517 studies, recruiting or not: 25% stop at 75 or younger and 13% at 65; 12% take children; 3% are for women only and 5% for men only; 24% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Atherosclerosis studies take

Of 55 phase 4 interventional studies under Atherosclerosis, half reached primary completion within 30 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 112 mo4–41 · 31 studies——
Phase 230 mo12–59 · 46 studies——
Phase 335 mo21–63 · 53 studies33 mo21–51 · 36 studies—
Phase 430 mo17–59 · 55 studies—36 mo24–59 · 45 studies
Interventional, no phase30 mo17–56 · 197 studies—30 mo17–56 · 177 studies
Observational62 mo31–153 · 169 studies—84 mo34–158 · 144 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 12, 2026.

Started recruiting1

Newly registered8

Show 3 more

Studies

Recruiting first, then most recently updated. Showing 50 of 1,517. Browse all 1,517 → or search them.